Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease pneumocystosis
Comorbidity C0003873|rheumatoid arthritis
Sentences 9
PubMedID- 26396551 pneumocystis jirovecii pneumonia in rheumatoid arthritis patients: risks and prophylaxis recommendations.
PubMedID- 24495443 Prophylaxis for pneumocystis pneumonia in patients with rheumatoid arthritis treated with biologics, based on risk factors found in a retrospective study.
PubMedID- 21384675 [clinical study of pneumocystis pneumonia in patients with rheumatoid arthritis].
PubMedID- 21881284 Intestinal perforation due to concomitant cytomegalovirus infection during treatment for pneumocystis jirovecii pneumonia in a patient with rheumatoid arthritis.
PubMedID- 23212592 Clinical characteristics and risk factors for pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis receiving adalimumab: a retrospective review and case-control study of 17 patients.
PubMedID- 20824796 Trends in hospitalizations for pneumocystis jiroveci pneumonia among patients with rheumatoid arthritis in the us: 1996-2007.
PubMedID- 24881737 Deterioration of the immune response induced by sulfamethoxazole-trimethoprim in a rheumatoid arthritis patient with pneumocystis jirovecii pneumonia.
PubMedID- 21971942 Prognosis of pneumocystis pneumonia complicated in patients with rheumatoid arthritis (ra) and non-ra rheumatic diseases.
PubMedID- 25313341 pneumocystis jirovecii pneumonia in a patient with rheumatoid arthritis treated with abatacept.

Page: 1